Liquidity & Technical
Senores Pharmaceuticals — Technical Analysis
SENORES · NSE · INR · as of 2026-05-12
IPO note: Senores listed December 2024. History covers ~17 months only. No 3y/5y returns, no beta, no golden/death cross data. All conclusions carry reduced confidence relative to a seasoned name.
Liquidity verdict: "Unknown" — shares outstanding not populated in data; market-cap-dependent metrics (% of MCap, liquidation runway) computed from estimated ₹4,367 Cr market cap (Dan tab). Treat sizing figures as indicative.
1 · Portfolio Verdict
Portfolio Verdict
2 · Price Snapshot
Price Snapshot
Price context: ₹950.4 sits inside the upper Bollinger band (upper ₹963.5), 22.9% above the 200-day SMA and 15.7% above the 50-day SMA. The intraday ATH of ₹979.8 was set on 2026-05-11; daily range is 3.56% on a 60-day median — elevated, which is typical for a mid-cap pharma but means slippage is material on large prints.
3 · Price + Moving Averages
Reading: The stock has been in a sustained uptrend since May 2025 lows (₹475). SMA50 crossed above SMA200 early in the history and the gap has widened. The Q1 2026 pullback from ₹865 to ₹765 (Jan–Feb correction) held well above both SMAs — a healthy reset. The April-May 2026 breakout has taken price to new ATH territory; the first test of ₹1,000 becomes the obvious next reference.
4 · Relative Performance — Company vs Benchmark
Data gap: Broad-market ETF (INDA) series was not populated in this run's benchmark data. Relative strength dimension scored 0 in the scorecard. SENORES is +70.6% from IPO price over ~17 months; whether this outpaced or matched the market cannot be confirmed from available data.
5 · Momentum Panel
RSI(14) — Last 8 Weeks
RSI reading: RSI peaked at 75.5 on 2026-04-20 — briefly overbought but not extreme. It has since cooled to 65.6: elevated-neutral, consistent with a strong trend. The March low of 35.3 (2026-03-23 washout) anchors the recent base from which the April breakout launched. Notably, RSI did not break below 50 during the April-May consolidation, which is a bullish characteristic.
MACD Histogram — Last 40 Trading Days
MACD reading: Histogram peaked at +15.78 on 2026-04-21, decelerating as price consolidated. A brief dip to −3.34 on 2026-05-06 (only 3 negative days) resolved immediately — bears had no follow-through. The current +1.88 and rising is a freshly bullish signal as the MACD line (34.4) remains above signal (32.5).
6 · Volume, Volatility & Sponsorship
Volume — Monthly Average Daily Volume
Realized Volatility 30d — Monthly
Unusual volume events:
Top Volume Spikes (by multiple vs 50d ADV)
Sponsorship read: Seven of the top ten volume days had positive returns. The three largest spikes (18.6×, 8.2×, 6.1×) all closed strongly. This is consistent with institutional accumulation — large players absorbing supply rather than distributing. The lone major distribution signal (2026-01-20, −2.7%) was immediately bought the next session at 3.5× ADV.
7 · Institutional Liquidity Panel
Liquidity Metrics
Liquidation runway (estimated at ₹4,367 Cr market cap):
Estimated Liquidation Runway (days)
Liquidity verdict: This is a capacity-constrained name. A 1% MCap position (₹43.7 Cr) takes 8–17 trading days to exit without moving the market. Funds above ₹5,207 Cr AUM cannot hold a 5% weight unless they own the float. The 20-day ADV expansion from ₹17.57 Cr (60d) to ₹24.96 Cr (20d) shows recent liquidity is meaningfully better than the trailing average — likely driven by the April-May price discovery phase. Entry should be staged over 5–10 days; do not use market orders on any ticket above ₹2 Cr.
8 · Technical Scorecard & Stance
Technical Scorecard — SENORES (2026-05-12)
Total: +4 of possible +5
Stance: Bullish
Price is in a confirmed Stage 2 uptrend: above both SMAs, positive MACD, volume-on-up-days pattern intact. The MACD's brief three-day negative (-3.3 to -1.4) followed by immediate recovery is the cleanest signal of the cycle — this is trend continuation, not exhaustion.
Three scenarios:
| Scenario | Trigger | Target |
|---|---|---|
| Bull — ATH break | Close above ₹1,000 on above-average volume | ₹1,100–1,200 (measured move off May base) |
| Base — range consolidation | Price oscillates ₹900–980 for 2–4 weeks | Re-entry near ₹880–900 on Bollinger midband touch |
| Bear — trend breakdown | Close below ₹850 on elevated volume | ₹780–800 (200d SMA + prior consolidation zone) |
Liquidity overlay: Maximum position for a ₹2,000 Cr fund at 5% weight = ₹100 Cr. At 20% ADV, that requires 20 days of patient execution. Treat ₹850 as the stop level before sizing to the full target — the execution lag means stops must be generous. For funds above ₹5,207 Cr, a 5% weight is not executable; consider 2–3% max.
One thing price is telling us that fundamentals aren't: The stock's ability to reclaim ₹930–950 post-ATH and hold after two years of post-IPO overhang suggests the float is largely in strong hands. A 17-month IPO that keeps making new highs without extended distribution is unusual; the volume sponsorship pattern (accumulation, not rotation) supports this read.
Source: price data via prices/daily; indicators computed by Tech agent 2026-05-12. SMA values at non-terminal monthly dates are linearly approximated from the computed array; ATH, Bollinger, and current-day values are exact.